+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Thyroid Function Testing Market Size, Share & Trends Analysis Report By End-use, By Test Type (TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others) By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 111 Pages
  • April 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953524
The LAMEA Thyroid Function Testing Market would witness market growth of 8.8% CAGR during the forecast period (2023-2031).

The Brazil market dominated the LAMEA Thyroid Function Testing Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $161.6 million by 2031. The Argentina market is showcasing a CAGR of 9.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 8.4% during (2024 - 2031).



Thyroid function testing has become more accessible and affordable due to advancements in laboratory automation, assay technologies, and point-of-care testing options. Automated immunoassays, chemiluminescent assays, and rapid point-of-care devices have improved testing efficiency, reduced turnaround times, and lowered costs, making this more accessible to patients and healthcare providers.

Thyroid function testing is undergoing rapid evolution, driven by technological advancements, shifting healthcare paradigms, and emerging trends in personalized medicine. For example, multiplexed assays and panel testing platforms are gaining demand for comprehensive thyroid function assessment, allowing simultaneous measurement of multiple thyroid hormones, autoantibodies, and biomarkers in a single sample.

The increasing incidence of thyroid cancer in Saudi Arabia is likely to have a significant impact on the market in the country. According to the data from the National Library of Medicine In Saudi Arabia, there were 2833 cases of TC in 2020, making it the second most common cancer in women (compared to 6.2% in men). Therefore, the growing prevalence of thyroid cancer and increasing aging population is driving the growth of the market.

Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Ulta Lab Tests, LLC
  • DHA Laboratory
  • Everly Health, Inc.
  • ZRT Laboratory LLC
  • Danaher Corporation
  • Thyrocare Technologies Limited
  • Siemens Healthineers AG (Siemens AG)
  • Abbott Laboratories

Market Report Segmentation

By End-use
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Research Laboratories & Institutes
By Test Type
  • TSH Test
  • Free T4 Test
  • T4 Test
  • T3 Test
  • Free T3 Test
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Thyroid Function Testing Market, by End-use
1.4.2 LAMEA Thyroid Function Testing Market, by Test Type
1.4.3 LAMEA Thyroid Function Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Thyroid Function Testing Market by End-use
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Diagnostic Laboratories Market by Country
4.3 LAMEA Clinics Market by Country
4.4 LAMEA Research Laboratories & Institutes Market by Country
Chapter 5. LAMEA Thyroid Function Testing Market by Test Type
5.1 LAMEA TSH Test Market by Country
5.2 LAMEA Free T4 Test Market by Country
5.3 LAMEA T4 Test Market by Country
5.4 LAMEA T3 Test Market by Country
5.5 LAMEA Free T3 Test Market by Country
5.6 LAMEA Others Market by Country
Chapter 6. LAMEA Thyroid Function Testing Market by Country
6.1 Brazil Thyroid Function Testing Market
6.1.1 Brazil Thyroid Function Testing Market by End-use
6.1.2 Brazil Thyroid Function Testing Market by Test Type
6.2 Argentina Thyroid Function Testing Market
6.2.1 Argentina Thyroid Function Testing Market by End-use
6.2.2 Argentina Thyroid Function Testing Market by Test Type
6.3 UAE Thyroid Function Testing Market
6.3.1 UAE Thyroid Function Testing Market by End-use
6.3.2 UAE Thyroid Function Testing Market by Test Type
6.4 Saudi Arabia Thyroid Function Testing Market
6.4.1 Saudi Arabia Thyroid Function Testing Market by End-use
6.4.2 Saudi Arabia Thyroid Function Testing Market by Test Type
6.5 South Africa Thyroid Function Testing Market
6.5.1 South Africa Thyroid Function Testing Market by End-use
6.5.2 South Africa Thyroid Function Testing Market by Test Type
6.6 Nigeria Thyroid Function Testing Market
6.6.1 Nigeria Thyroid Function Testing Market by End-use
6.6.2 Nigeria Thyroid Function Testing Market by Test Type
6.7 Rest of LAMEA Thyroid Function Testing Market
6.7.1 Rest of LAMEA Thyroid Function Testing Market by End-use
6.7.2 Rest of LAMEA Thyroid Function Testing Market by Test Type
Chapter 7. Company Profiles
7.1 Quest Diagnostics Incorporated
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Product Launches and Product Expansions:
7.1.5 SWOT Analysis
7.2 Laboratory Corporation of America Holdings
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Product Launches and Product Expansions:
7.2.5 SWOT Analysis
7.3 Ulta Lab Tests, LLC
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 DHA Laboratory
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Everly Health, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 ZRT Laboratory LLC
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Product Launches and Product Expansions:
7.6.3 SWOT Analysis
7.7 Danaher Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 Thyrocare Technologies Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Recent strategies and developments:
7.8.4.1 Business Expansions:
7.8.5 SWOT Analysis
7.9 Siemens Healthineers AG (Siemens AG)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product Launches and Product Expansions:
7.9.6 SWOT Analysis
7.10. Abbott Laboratories
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis

Companies Mentioned

  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Ulta Lab Tests, LLC
  • DHA Laboratory
  • Everly Health, Inc.
  • ZRT Laboratory LLC
  • Danaher Corporation
  • Thyrocare Technologies Limited
  • Siemens Healthineers AG (Siemens AG)
  • Abbott Laboratories

Methodology

Loading
LOADING...